Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
EMEA Statement on the safety of Gardasil
Notice type:
Advisory
Date:
24/01/2008
Product name or type:
Gardasil
Active Substance:
Human Papillomavirus Vaccine
Problem Or Issue:
The European Medicines Agency (EMEA) has issued a statement on the safety of Gardasil following reports of deaths in women who had previously received the vaccine, including two cases which occurred in the European Union (Austria and Germany). The EU cases were reported as part of the continuous monitoring of the safety of medicines. In both cases, the cause of death was not identified and a causal relationship between administration of Gardasil and the deaths of the women has not been established. On the basis of the currently available information, the EMEA’s Committee for Medicinal Products for Human Use is of the opinion that the benefits of Gardasil continue to outweigh its risks and that no changes to the product information are necessary.
Background Information Or Related Documents:
EMEA Statement on the safety of Gardasil Document
« Back
Date Printed: 20/04/2024